Header

UZH-Logo

Maintenance Infos

Cerebral sinus venous thrombosis in Swiss children


Grunt, S; Wingeier, K; Wehrli, E; Boltshauser, E; Capone, A; Fluss, J; Gubser-Mercati, D; Jeannet, P Y; Keller, E; Marcoz, J P; Schmitt-Mechelke, T; Weber, P; Weissert, M; Steinlin, M (2010). Cerebral sinus venous thrombosis in Swiss children. Developmental Medicine and Child Neurology, 52(12):1145-1150.

Abstract

AIM: to describe the characteristics of paediatric cerebral sinus venous thrombosis (CSVT) in Switzerland.

METHOD: data on clinical features, neuroimaging, risk factors, and treatment were collected for all children in Switzerland younger than 16 years of age who had CSVT between January 2000 and December 2008. A follow-up examination and a cognitive assessment were performed (mean follow-up period 26mo). Differences between neonates and children (patients older than 28d) were assessed and predictors of outcome were determined.

RESULTS: twenty-one neonates (14 males, seven females; mean age 9d, SD 8d) and 44 children (30 males, 14 females; mean age 8y 7mo, SD 4y 5mo) were reported. The incidence of paediatric CSVT in Switzerland was 0.558 per 100000 per year. In neonates, the deep venous system was more often involved and parenchymal injuries were more common. The strongest predictor of poor outcome was neonatal age (odds ratio 17.8, 95% confidence interval 0.847-372.353). Most children showed global cognitive abilities within the normal range, but impairments in single cognitive subdomains were frequent.

INTERPRETATION: paediatric CSVT is rare. Its outcome is poor in neonates. Most children have good neurological outcomes, but some patients have individual neuropsychological impairments.

Abstract

AIM: to describe the characteristics of paediatric cerebral sinus venous thrombosis (CSVT) in Switzerland.

METHOD: data on clinical features, neuroimaging, risk factors, and treatment were collected for all children in Switzerland younger than 16 years of age who had CSVT between January 2000 and December 2008. A follow-up examination and a cognitive assessment were performed (mean follow-up period 26mo). Differences between neonates and children (patients older than 28d) were assessed and predictors of outcome were determined.

RESULTS: twenty-one neonates (14 males, seven females; mean age 9d, SD 8d) and 44 children (30 males, 14 females; mean age 8y 7mo, SD 4y 5mo) were reported. The incidence of paediatric CSVT in Switzerland was 0.558 per 100000 per year. In neonates, the deep venous system was more often involved and parenchymal injuries were more common. The strongest predictor of poor outcome was neonatal age (odds ratio 17.8, 95% confidence interval 0.847-372.353). Most children showed global cognitive abilities within the normal range, but impairments in single cognitive subdomains were frequent.

INTERPRETATION: paediatric CSVT is rare. Its outcome is poor in neonates. Most children have good neurological outcomes, but some patients have individual neuropsychological impairments.

Statistics

Citations

Dimensions.ai Metrics
34 citations in Web of Science®
34 citations in Scopus®
55 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

1 download since deposited on 22 Jan 2011
0 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2010
Deposited On:22 Jan 2011 08:40
Last Modified:17 Feb 2018 17:52
Publisher:Wiley-Blackwell
ISSN:0012-1622
Additional Information:Comment in: Dev Med Child Neurol. 2010 Dec;52(12):1080-1.
OA Status:Closed
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1111/j.1469-8749.2010.03722.x
PubMed ID:20573178

Download